treatment

EU drug agency starts evaluating new COVID-19 treatment

EU drug agency starts evaluating new COVID-19 treatment

  • Xevudy is a so-called monoclonal antibody treatment, a laboratory-made version of virus-blocking antibodies that help fight off infections
  • European Medicines Agency said it has begun evaluating an application for marketing authorization
By AP ·